| OSMCX | TQTIX | OSMCX / TQTIX | |
| Total Expense Ratio | 2.13 | 1.11 | 192% |
| Annual Report Gross Expense Ratio | 2.13 | 1.17 | 182% |
| Fund Existence | 28 years | 9 years | - |
| Gain YTD | 15.981 | 29.108 | 55% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 100000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.73B | 121M | 2,254% |
| Annual Yield % from dividends | 0.48 | 2.33 | 20% |
| Returns for 1 year | 0.82 | 24.41 | 3% |
| Returns for 3 years | 2.40 | 43.76 | 5% |
| Returns for 5 years | -27.38 | 16.39 | -167% |
| Returns for 10 years | 7.46 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PHSZX | 50.44 | 0.35 | +0.70% |
| PGIM Jennison Health Sciences Z | |||
| DTCAX | 21.26 | 0.06 | +0.28% |
| BNY Mellon Sust US Equity A | |||
| AMIDX | 15.38 | N/A | N/A |
| Amana Developing World Institutional | |||
| MSVOX | 6.33 | N/A | N/A |
| Morgan Stanley Vitality Portfolio R6 | |||
| PWCIX | 94.47 | -0.14 | -0.15% |
| Principal Capital Appreciation Inst | |||